Janssen Forms Global Public Health Group To Deliver Its Medicines To Developing World
This article was originally published in PharmAsia News
Executive Summary
With the formation of the GPH group, Janssen joins GSK and Sanofi in putting corporate focus on developing and delivering affordable medicines for developing countries. But where GSK seeks to improve outcomes and turn a profit, for now Janssen’s first priority is human health.